Diabetic cardiomyopathy and its prevention by nrf2: current status.
about
Haeme oxygenase signalling pathway: implications for cardiovascular diseaseAntioxidant Properties of Whole Body Periodic Acceleration (pGz)Restoration of Nrf2 Signaling Normalizes the Regenerative Niche.Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed miceProhibitin overexpression improves myocardial function in diabetic cardiomyopathy.Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathyGlucose Homeostasis and Cardiovascular Alterations in Diabetes.Oxidative stress in mesenchymal stem cell senescence: regulation by coding and non-coding RNAs.Aspalathin Protects the Heart against Hyperglycemia-Induced Oxidative Damage by Up-Regulating Nrf2 Expression.Pathophysiological Fundamentals of Diabetic Cardiomyopathy.Role of Nrf2 Signaling in the Regulation of Vascular BK Channel β1 Subunit Expression and BK Channel Function in High-Fat Diet-Induced Diabetic Mice.The Role of the Nrf2/ARE Antioxidant System in Preventing Cardiovascular Diseases.An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease.Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy.Regulation of vascular large-conductance calcium-activated potassium channels by Nrf2 signalling.Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.Paradoxical cardiotoxicity of intraperitoneally-injected epigallocatechin gallate preparation in diabetic mice.
P2860
Q27002692-BEBCDD56-173C-4B4E-945D-B748114292A6Q27303654-B4677685-A4E8-4523-8B99-FA546420E9C5Q35863707-6E2194DF-09F8-47CD-A4DF-2A1BF5BD1C53Q36157579-0972240E-1B67-41A8-BED6-0D209DB90847Q36729347-E38FB9FF-3E6C-4B37-9ED3-0A0DB8364617Q37745344-DD326FE7-2909-4CD7-9DE5-573C5619FC7EQ38596700-8B200CB7-248C-47D2-A31B-327BA7FD7916Q38648719-6BC05EB0-24EF-49CA-9C7F-E600628CEDFFQ38720805-EDC926BE-93A1-4144-A6EC-B033352E4AF1Q39195672-219C2EE6-E6F4-4799-8AA6-D015C999E5ECQ41972825-9066E21C-277F-4B60-B084-94F734B3AEE5Q42005885-ADC0D608-22A3-4A7D-9C51-0B61C570794BQ48254541-B5838BD2-EC0F-43D6-8C46-B13FA76DB001Q48273909-558E5586-6956-4F5C-A244-E491FE2D9827Q49783549-39A30701-4D21-47DD-AFC8-5B2CD54159EEQ51042757-9AE5B231-776E-46FE-93F5-050E9EE45C4FQ52694977-23AC9B7E-E6AE-4E15-BAD3-FCDAACF2E6FAQ54108759-149B372C-F8D0-4E20-8701-E3F7C44E421B
P2860
Diabetic cardiomyopathy and its prevention by nrf2: current status.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Diabetic cardiomyopathy and its prevention by nrf2: current status.
@en
type
label
Diabetic cardiomyopathy and its prevention by nrf2: current status.
@en
prefLabel
Diabetic cardiomyopathy and its prevention by nrf2: current status.
@en
P2093
P2860
P1476
Diabetic cardiomyopathy and its prevention by nrf2: current status.
@en
P2093
P2860
P304
P356
10.4093/DMJ.2014.38.5.337
P577
2014-10-01T00:00:00Z